首页> 外文期刊>Journal of investigative medicine >Biomarkers of acute kidney injury: early diagnosis, pathogenesis, and recovery.
【24h】

Biomarkers of acute kidney injury: early diagnosis, pathogenesis, and recovery.

机译:急性肾损伤的生物标志物:早期诊断,发病机制和恢复。

获取原文
获取原文并翻译 | 示例
           

摘要

This review article represents the proceedings from the translational research symposium presented at the Federation of American Societies for Experimental Biology/American Federation for Medical Research (FASEB/AFMR) meeting in May 2007 in Washington, DC. This research symposium consisted of four talks, which are individually summarized below. The first talk gave a general overview of the biomarkers in the setting of acute kidney injury (AKI), along with some data from clinical biomarker studies. The second talk discussed the preclinical studies of the emerging biomarkers in the area of AKI. The third talk discussed the biomarkers of AKI after deceased kidney transplantation, which is a unique model of kidney ischemia-reperfusion injury. The final talk discussed the role of circulating stem cells in renal tubule regeneration after ischemic injury and if they have potential for biomarkers of recovery or therapeutic intervention.
机译:这篇评论文章代表了在2007年5月于华盛顿特区举行的美国实验生物学学会联合会/美国医学研究联合会(FASEB / AFMR)会议上提出的转化研究研讨会的论文集。该研究研讨会包括四个演讲,下面分别进行总结。第一个演讲概述了急性肾损伤(AKI)背景下的生物标志物,以及来自临床生物标志物研究的一些数据。第二讲讨论了AKI领域新兴生物标志物的临床前研究。第三个演讲讨论了已故肾脏移植后AKI的生物标志物,这是肾脏缺血再灌注损伤的独特模型。最后的演讲讨论了循环干细胞在缺血性损伤后在肾小管再生中的作用,以及它们是否具有恢复或治疗干预的生物标志物的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号